<DOC>
	<DOCNO>NCT01001637</DOCNO>
	<brief_summary>Curcumin show impact several different pathway neuroprotection , however clinical trial show positive result , due poor bioavailability curcumin . This study design determine efficacy safety high-bioavailability curcumin formulation ( Longvida ) subject Alzheimer 's disease .</brief_summary>
	<brief_title>Efficacy Safety Curcumin Formulation Alzheimer 's Disease</brief_title>
	<detailed_description>Curcumin polyphenolic molecule comprises approximately 3-5 % turmeric ( Curcuma longa ) root , give spice characteristic yellow color . Because anti-inflammatory , anti-amyloid , antioxidant property , curcumin show positive effect animal model Alzheimer 's disease ( AD ) . However , six month human study conduct unformulated curcumin show insignificant trend , due limited bioavailability brain permeability unformulated curcumin . In animal model AD , oral dose solid-lipid curcumin particle ( SLCP Longvida ) significantly reduce memory deficit impact biomarkers well unformulated curcumin . This study determine potential efficacy safety highly absorbed SLCP curcumin subject AD .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>Male Female age ≥ 50 . Diagnosed probable AD use NINDSADRDA research criterion . MMSE score ≥5 ≤20 . No history significant psychiatric nonAD neurological disease . An available caregiver monitor administer medication accompany subject every clinical visit . On stable dos concomitant medication least one month prior start study medication . Current recent major psychiatric illness meet DSMIV criterion ( i.e . bipolar disorder , schizophrenia ) . Significant uncontrolled systemic illness ( i.e . chronic renal failure , chronic liver disease , poorly control diabetes , poorly control congestive heart failure ) . Recent history gastrointestinal bleeding ulceration . Alcoholism substance abuse within past year per DSMIV criterion . Familial , autosomal dominant Alzheimer 's disease due mutation know gene ( Presenilin1 , Presenilin2 , Amyloid Precursor Protein ) .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>curcumin</keyword>
	<keyword>alzheimer 's</keyword>
	<keyword>longVida</keyword>
	<keyword>dementia</keyword>
</DOC>